Mapping the English and Chinese versions of the functional assessment of cancer therapy-general to the EQ-5D utility index

Value in Health

Volumn 12, Issue 2, 2009, Pages 371-376

  Cheung, Yin Bun ^a,b   Thumboo, Julian ^c   Gao, Fei ^d   Ng, Gim Yew ^d   Pang, Grace ^d   Koo, Wen Hsin ^d   Sethi, Vijay Kumar ^d   Wee, Joseph ^d   Goh, Cynthia ^d  

^a CTERU   (Singapore)

^b Clinical Trials and Epidemiology Research Unit   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Cancer; EQ 5D; FACT G; Quality of life; Utility

Indexed keywords

ADULT; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE INDEX; QUESTIONNAIRE; SINGAPORE; VALIDATION PROCESS; ADAPTIVE BEHAVIOR; ALGORITHM; COMPARATIVE STUDY; HEALTH STATUS INDICATOR; INFORMATION PROCESSING; MIDDLE AGED; NEOPLASMS; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; REGRESSION ANALYSIS; STANDARDS; STATISTICAL MODEL; VALIDATION STUDY;

ADAPTATION, PSYCHOLOGICAL; ALGORITHMS; DATA COLLECTION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LANGUAGE; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SINGAPORE;

EID: 60349125461     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00448.x     Document Type: Article

References (26)

1. Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality adjusted life-years by different preference-based instruments. Med Care 2003 41 : 791 801.
2. Kopec JA, Willison KD. A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol 2003 56 : 317 25.
3. Lyman GH. Economic analysis of cancer clinical trials. In : Crowley J, ed. Handbook of Statistics in Clinical Oncology. New York : Marcel Dekker, 2001.
4. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993 11 : 570 9.
5. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997 35 : 1095 108.
6. Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ 2002 11 : 341 53.
7. Lawrence WF, Fleishman JA. Predicting EuroQoL EQ-5D preference scores from the SF-12 health survey in a nationally representative sample. Med Decis Making 2004 24 : 160 9.
8. Sullivan PW, Ghushchyan V. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Med Decis Making 2006 26 : 401 9.
9. Brennan DS, Spencer AJ. Mapping oral health related quality of life to generic health state values. BMC Health Serv Res 2006 6 : 96.
10. Sengupta N, Nichol MB, Wu J, Globe D. Mapping the SF-12 to the HUI3 and VAS in a managed care population. Med Care 2004 42 : 927 37.
11. Wu EQ, Mulani P, Farrell MH, Sleep D. Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. Value Health 2007 10 : 408 14.
12. Kind P, Macran S. Eliciting social preference weights for Functional Assessment of Cancer Therapy-lung health states. Pharmacoeconomics 2005 23 : 1143 53.
13. Lamers LM, Uyl-de Groot CA, Buijt I. The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scale. Pharmacoeconomics 2007 25 : 591 603.
14. Pickard AS, Dobrez D, Cella D. Eliciting social preference weights for functional assessment of cancer therapy-lung health states. Pharmacoeconomics 2006 24 : 293 4.
15. Kind P, Macran S. Authors' reply. Pharmacoeconomics 2006 24 : 294 6.
16. Dobrez D, Cella D, Pickard AS, et al. Estimation of patient preference-based utility weights from the functional assessment of cancer therapy-general. Value Health 2007 10 : 266 72.
17. Graddol D. The future of language. Science 2004 303 : 1329 31.
18. Luo N, Chew LH, Fong KY, et al. Do English and Chinese EQ-5D versions demonstrate measurement equivalence? Health Qual Life Outcomes 2003 1 : 7.
19. Cheung YB, Thumboo J, Goh C, et al. The equivalence and difference between the English and Chinese versions of two major cancer-specific health-related quality of life questionnaires. Cancer 2004 101 : 2874 80.
20. Gao F, Ng GY, Cheung YB, et al. The Singaporean English and Chinese versions of the EQ-5D achieved measurement equivalence in cancer patients. J Clin Epidemiol 2008;Jul 9 [Epub ahead of print].
21. Cheung YB, Ng GY, Wong LC, et al. Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index - Cancer (Chinese). Ann Acad Med Singapore 2003 32 : 376 80.
22. Luo N, Chew LH, Fong KY, et al. Validity and reliability of the EQ-5D self-reported questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res 2003 12 : 87 92.
23. Luo N, Chew LH, Fong KY, et al. Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Ann Acad Med Singapore 2003 32 : 685 90.
24. Cheung YB, Goh C, Thumboo J, et al. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. J Clin Oncol 2005 23 : 4936 44.
25. Blagden SP, Charman SC, Sharples LD, et al. Performance status score: do patients and their oncologists agree? Br J Cancer 2003 89 : 1022 27.
26. Jolliffe D, Krushelnytskyy B, Semykina A. Censored least absolute deviations estimator. Stata Tech Bull 2001 10 : 240 4.